New Thoughts on Thought Disorders in Parkinson's Disease: Review of Current Research Strategies and Challenges

by Jennifer G. Goldman
Published 2011-01-01

Abnormal alpha-synuclein reduces nigral voltage-dependent anion channel 1 in sporadic and experimental Parkinson's disease

by Yaping Chu, Jennifer G. Goldman, Leo Kelly, Yinzhen He, Tracy Waliczek, Jeffrey H. Kordower
Published 2014-09-01

The effects of dual-task cognitive interference on gait and turning in Huntington's disease.

by Nicollette L Purcell, Jennifer G Goldman, Bichun Ouyang, Yuanqing Liu, Bryan Bernard, Joan A O'Keefe
Published 2020-01-01

Peripheral electrical stimulation to reduce pathological tremor: a review

by Alejandro Pascual-Valdunciel, Grace W. Hoo, Simon Avrillon, Filipe Oliveira Barroso, Jennifer G. Goldman, Julio C. Hernandez-Pavon, José L. Pons
Published 2021-02-01

Evaluation of an Interdisciplinary Screening Program for People With Parkinson Disease and Movement Disorders

by Uzma Khan, OTR/L, Laura Stoff, MPH, J. Diego Yahuaca, BSc, Bavna Bhagavat, BSc, Santiago Toledo, MD, Jennifer G. Goldman, MD, MS, Tanya Simuni, MD, Miriam Rafferty, DPT, PhD
Published 2020-09-01

α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease

by Cecilia S. Lindestam Arlehamn, Rekha Dhanwani, John Pham, Rebecca Kuan, April Frazier, Juliana Rezende Dutra, Elizabeth Phillips, Simon Mallal, Mario Roederer, Karen S. Marder, Amy W. Amara, David G. Standaert, Jennifer G. Goldman, Irene Litvan, Bjoern Peters, David Sulzer, Alessandro Sette
Published 2020-04-01

Lewy Body Dementia Association’s Industry Advisory Council: proceedings of the second annual meeting

by Jennifer G. Goldman, Bradley F. Boeve, Melissa J. Armstrong, Doug R. Galasko, James E. Galvin, David J. Irwin, James B. Leverenz, Karen Marder, Victor Abler, Kevin Biglan, Michael C. Irizarry, Bill Keller, Robert Lai, Leanne Munsie, Michael Belleville, Ondrea Chaney, Ian Richard, Angela Taylor, Todd Graham
Published 2021-07-01

Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials

by Jennifer G. Goldman, Leah K. Forsberg, Bradley F. Boeve, Melissa J. Armstrong, David J. Irwin, Tanis J. Ferman, Doug Galasko, James E. Galvin, Daniel Kaufer, James Leverenz, Carol F. Lippa, Karen Marder, Victor Abler, Kevin Biglan, Michael Irizarry, Bill Keller, Leanne Munsie, Masaki Nakagawa, Angela Taylor, Todd Graham
Published 2020-10-01